Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection.
Neurology
; 95(15): e2109-e2118, 2020 10 13.
Article
in English
| MEDLINE | ID: covidwho-638341
ABSTRACT
OBJECTIVE:
To report a case of a patient infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who acutely developed a hypokinetic-rigid syndrome.METHODS:
Patient data were obtained from medical records from the Hospital Universitario 12 de Octubre in Madrid, Spain. [123I]-ioflupane dopamine transporter (DaT) SPECT images were acquired 4 hours after a single dose of 185 MBq of 123I-FP-CIT. Quantitative analysis was performed with DaTQUANT software providing the specific binding ratio and z score values of the striatum.RESULTS:
We report a previously healthy 58-year-old man who developed hyposmia, generalized myoclonus, fluctuating and transient changes in level of consciousness, opsoclonus, and an asymmetric hypokinetic-rigid syndrome with ocular abnormalities after a severe SARS-CoV-2 infection. DaT-SPECT confirmed a bilateral decrease in presynaptic dopamine uptake asymmetrically involving both putamina. Significant improvement in the parkinsonian symptoms was observed without any specific treatment.CONCLUSION:
This case study provides clinical and functional neuroimaging evidence to support that SARS-CoV-2 can gain access to the CNS, affecting midbrain structures and leading to neurologic signs and symptoms.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Parkinson Disease, Postencephalitic
/
Pneumonia, Viral
/
Putamen
/
Coronavirus Infections
Type of study:
Case report
/
Prognostic study
Topics:
Long Covid
/
Vaccines
Limits:
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Neurology
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS